Drug details:
Molecular formula: C₁₆H₁₁F₃N₄O₄S

Standard name: 2-[(6-nitro-1H-benzimidazol-2-yl)sulfanyl]-N-[4-(trifluoromethoxy)phenyl]acetamide

Synonyms:

2-[(5-nitro-1H-1,3-benzimidazol-2-yl)sulfanyl]-N~1~-[4-(trifluoromethoxy)phenyl]acetamide 2-[(5-nitro-1H-benzimidazol-2-yl)thio]-N-[4-(trifluoromethoxy)phenyl]acetamide

Curated SMILES: O=C(CSC1=NC2=CC([N+](=O)[O-])=CC=C2N1)NC1=CC=C(OC(F)(F)F)C=C1

Evidence for compound's anti-virulence activity:

Pseudomonas
Related VFcategory: Biofilm
Target: MvfR
Drug effect: Inhibits MvfR-regulated virulence functions.
Max phase: Preclinical (in vitro)
Publication:
Starkey M, et al., 2014. Identification of anti-virulence compounds that disrupt quorum-sensing regulated acute and persistent pathogenicity. PLoS Pathog 10(8):e1004321.